Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Wrong administration route; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate route of vaccination in a 2-month-old female patient who received Rota (Rotarix lyophilized formulation) for prophylaxis. On 16-JAN-2025, the patient received Rotarix lyophilized formulation. On 16-JAN-2025, an unknown time after receiving Rotarix lyophilized formulation, the patient experienced inappropriate route of vaccination (Verbatim: Wrong administration route). The outcome of the inappropriate route of vaccination was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 21-JAN-2025 A medical assistant called and reported that they gave out a Rotarix lyophilized to a 2 month old baby, instead of an oral administration, they injected the medication which led to inappropriate route of vaccination. It was given in the left thigh, instead of oral. The vaccine administration facility is the same as primary reporter. During the call, the healthcare professional did not provide any lot number nor expiry date, however, she said that this was the Rotarix lyophilized version.